Expansion of Clinical Development of RVU120 in Low-Risk Myelodysplastic Syndromes (LR-MDS) ...Middle East

PR Newswire - News
KRAKOW, Poland, Oct. 20, 2023 /PRNewswire/ -- Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel small molecule therapies addressing emerging targets in oncology, announced today that it entered into a Clinical Trial Financial Support...

Hence then, the article about expansion of clinical development of rvu120 in low risk myelodysplastic syndromes lr mds was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Expansion of Clinical Development of RVU120 in Low-Risk Myelodysplastic Syndromes (LR-MDS) )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News